快而精医药 QGEN 深 沪
已收盘 12-12 16:00:00 美东时间
45.22
-0.220
-0.48%
华盛通- 最 高45.30
- 今 开45.03
- 成交量 97.72万股
- 最 低 44.82
- 昨 收 45.44
- 总市值 98.13亿
- 52周最高 51.875
- 市盈率 静 118.19
- 换手率 0.45%
- 52周最低 37.38
- 委 比 -92.48%
- 总股本 2.17亿
- 历史最高 59.6593
- 量 比 0.83
- 振 幅 1.06%
- 历史最低 9.6831
- 每 手 1
- 风险率 3.35%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 绩后分化！甲骨文遭14家大行集体下调目标价；新思科技、Planet获多家机构上调目标价！
今日重点评级关注：HC Wainwright & Co.：维持Moleculin Biotech"买入"评级，目标价从4美元升至22美元；HC Wainwright & Co.：上调Soluna Holdings评级至"买入"，目标价5美元
12-12 10:24
Citigroup Downgrades Qiagen to Neutral, Lowers Price Target to $50
Citigroup analyst Patrick Donnelly downgrades Qiagen (NYSE:QGEN) from Buy to Neutral and lowers the price target from $55 to $50.
12-11 22:11
QIAGEN Launches QIAsymphony Connect For Liquid Biopsy Workflows And Highlights HRD And CGP Innovations At AMP 2025
QIAsymphony Connect, the next generation of automated nucleic acid purification platform, to be shown at AMP 2025 as early access phase begins ahead of full release in mid-2026QIAGEN showcases Sample to Insight workflows
11-10 14:39
Qiagen Raises FY2025 Adj EPS Guidance from $2.35 to $2.38 vs $2.37 Est
Qiagen (NYSE:QGEN) raises FY2025 Adj EPS guidance from $2.35 to $2.38 vs $2.37 analyst estimate..
11-05 02:14
Qiagen Q3 Adj. EPS $0.61 Beats $0.59 Estimate, Sales $533.000M Beat $525.929M Estimate
Qiagen (NYSE:QGEN) reported quarterly earnings of $0.61 per share which beat the analyst consensus estimate of $0.59 by 4.1 percent. This is a 3.39 percent increase over earnings of $0.59 per share from the same period
11-05 02:12
Earnings Scheduled For November 4, 2025
Companies Reporting Before The Bell • Sequans Communications (NYSE:SQNS) is lik...
11-04 19:12
QIAGEN Launches Automated EZ2 DNA Investigator Sep&Prep Kit To Automate Sexual Assault Sample Processing And Enhance Forensic DNA Recovery
New EZ2 DNA Investigator Sep&Prep Kit automates sexual assault sample processing, improving sperm DNA recovery and separation from victim DNAWorkflow on EZ2 Connect Fx delivers high-quality DNA in under 2.5 hours,
10-31 05:11
Qualigen Therapeutics Partners with BitGo to Execute First Multi-Asset C10 Treasury Allocation
Qualigen Therapeutics Inc. (NASDAQ: QLGN), a biotechnology company majority owned by Faraday Future, has entered into a strategic partnership with BitGo, a leading digital asset infrastructure company, to support its C10 treasury strategy. This strategy involves accumulating and compounding a market-cap-weighted basket of the world's top 10 crypto assets (excluding stablecoins). Through this collaboration, Qualigen will leverage BitGo's comprehen...
10-23 20:05
Qiagen N.V. Announces Voting Rights Notification by AFM
Qiagen ( ($QGEN) ) has issued an announcement. Qiagen N.V., a company based in ...
10-08 04:37
Qiagen Receives AFM Notification on Barclays’ Shareholdings
Qiagen ( ($QGEN) ) has shared an announcement. Qiagen N.V., a company based in ...
09-19 04:37
